Curion, Fabiola
Rich-Griffin, Charlotte
Agarwal, Devika
Ouologuem, Sarah
Rue-Albrecht, Kevin
May, Lilly
Garcia, Giulia E. L.
Heumos, Lukas
Thomas, Tom
Lason, Wojciech
Sims, David
Theis, Fabian J.
Dendrou, Calliope A. http://orcid.org/0000-0003-1179-4021
Funding for this research was provided by:
Wellcome Trust (204290/Z/16/Z)
Medical Research Council (MR/T030410/1, MR/R015708/1)
Rosetrees Trust (R35579/AA002/M85-F2)
NIHR Oxford Biomedical Research Centre (BRCRCF10-04)
Deutsche Forschungsgemeinschaft (SFB- TRR 338/1 2021 –452881907)
Article History
Received: 14 March 2023
Accepted: 25 June 2024
First Online: 8 July 2024
Declarations
:
: Not relevant to our study.
: Not relevant to our study.
: FJT consults for Immunai Inc., Singularity Bio B.V., CytoReason Ltd, and Omniscope Ltd, and has ownership interest in Dermagnostix GmbH and Cellarity. LH is an employee of Lamin Labs. The other authors declare no competing interests.